Congress leaders on Sunday expressed concerns over the permission granted for restricted use of the coronavirus vaccine developed by Bharat Biotech, even as the pharmaceutical company was yet to complete phase 3 trials, PTI reported.
Rajya Sabha MP Anand Sharma said that the matter of granting authorisation to the vaccine use needs to be taken carefully as no country has done away with the mandatory phase 3 trials and verification of data. “The Health Ministry needs to give cogent reasons for dispensing with the mandatory protocols and requirements in this case, since it involves the health and safety of frontline workers who will be vaccinated under the restricted category,” Sharma, who heads the Parliamentary panel on Home Affairs, told PTI.
Earlier on Sunday, Drugs Controller General of India chief VG Somani announced the approval for restricted emergency use of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin shots.
Covaxin is the country’s…
